Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trialNicola G. Ghazi, Fowzan S. Alkuraya, Sanford L. Boye et al.|Human Genetics|2016Cited by 242
Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of <i>MERTK</i> Associated Retinitis PigmentosaThomas J. Conlon, William W. Hauswirth, Wen‐Tao Deng et al.|Human Gene Therapy Clinical Development|2013Cited by 95
Stability and Safety of an AAV Vector for Treating <i>RPGR-ORF15</i> X-Linked Retinitis PigmentosaWen‐Tao Deng, William W. Hauswirth, Frank M. Dyka et al.|Human Gene Therapy|2015Cited by 55
Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 MiceChunjuan Song, Guojie Ye, Thomas J. Conlon et al.|Human Gene Therapy Clinical Development|2018Cited by 19